ASPIRO phase 1/2 gene therapy trial in X-linked motubular myopathy (XLMTM): update on preliminary safety and efficacy findings

被引：1
|
作者：
Dowling, J. [1 ]
Shieh, P. [2 ]
Kuntz, N. [3 ]
Bonnemann, C. [4 ]
Muller-Felber, W. [5 ]
Lawlor, M. [6 ]
Servais, L. [7 ]
Smith, B. [8 ]
Noursalehi, M. [9 ]
Rico, S. [9 ]
Prasad, S. [9 ]
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Childrens Hosp Chicago, Chicago, IL USA
[4] NIH, Bldg 10, Bethesda, MD 20892 USA
[5] Univ Munich, Munich, Germany
[6] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[7] Hop Armand Trousseau, Paris, France
[8] Univ Florida, Gainesville, FL USA
[9] Audentes Therapeut, San Francisco, CA USA
来源：
NEUROMUSCULAR DISORDERS | 2019年 / 29卷
关键词：
D O I：
10.1016/j.nmd.2019.06.593
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O.39
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [41] Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
    MacLaren, Robert E.
    Groppe, Markus
    Barnard, Alun R.
    Cottriall, Charles L.
    Tolmachova, Tanya
    Seymour, Len
    Clark, K. Reed
    During, Matthew J.
    Cremers, Frans P. M.
    Black, Graeme C. M.
    Lotery, Andrew J.
    Downes, Susan M.
    Webster, Andrew R.
    Seabra, Miguel C.
    LANCET, 2014, 383 (9923): : 1129 - 1137
  • [42] INCEPTUS pre-phase 1, prospective, non-interventional, natural history run-in study to evaluate subjects aged 3-years and younger with X-linked myotubular myopathy: preliminary findings
    Shieh, P.
    Mueller-Felber, W.
    Smith, B.
    Bonnemann, C.
    Dowling, J.
    Kuntz, N.
    Muntoni, F.
    Servais, L.
    Bilder, D.
    Duong, T.
    Graham, R.
    Jain, M.
    Lawlor, M.
    MacBean, V.
    Noursalehi, M.
    Pitts, T.
    Rafferty, G.
    Rico, S.
    Prasad, S.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S70 - S70
  • [43] Preliminary Safety and Efficacy Results from an Open-Label, Dose-Escalation Pilot Gene Therapy Study of FT-002 in Subjects with RPGR Gene Mutation Associated X-Linked Retinitis Pigmentosa (XLRP)
    Wu, Jihong
    Sui, Ruifang
    MOLECULAR THERAPY, 2024, 32 (04) : 451 - 452
  • [44] AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis
    Scruggs, Brittni A.
    Bhattarai, Sajag
    Cherascu, Ioana
    Helms, Megan
    Salesevic, Adisa
    Laird, Joseph
    Baker, Sheila A.
    Tucker, Budd
    Drack, Arlene V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [45] AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis
    Scruggs, Brittni A.
    Bhattarai, Sajag
    Helms, Megan
    Cherascu, Ioana
    Salesevic, Adisa
    Stalter, Elliot
    Laird, Joseph
    Baker, Sheila A.
    Drack, Arlene, V
    PLOS ONE, 2022, 17 (12):
  • [46] Six Month Findings from a Phase 1/2 Clinical Study of Subretinal Gene Therapy Drug AGTC-501 for X-Linked Retinitis Pigmentosa Show Clinically Meaningful Improvement in Macular Sensitivity
    Yang, Paul
    Lauer, Andreas
    Pennesi, Mark E.
    Birch, David G.
    Spencer, Rand
    Sisk, Robert A.
    Iannaccone, Alessandro
    Leone, Erin
    Halliman, Deanine
    Ihekoromadu, Nnenna
    Feinsod, Matthew
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2021, 62 (08)
  • [47] SAFETY AND EFFICACY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF OCU400 MODIFIER GENE THERAPY FOR TREATMENT OF RETINITIS PIGMENTOSA
    Upadhyay, A. K.
    Qamar, H.
    Matloob, S.
    Chavali, M.
    CYTOTHERAPY, 2024, 26 (06) : S18 - S18
  • [48] Safety and preliminary efficacy of LYS-GM101 gene therapy in patients with GM1 gangliosidosis: Results of a phase I/II openlabel clinical trial
    Ghosh, Arunabha
    Heron, Benedicte
    Donald, Aimee
    Chang, Harriet
    Furness, Laura
    Movsesyan, Nina
    Ravelli, Claudia
    Jones, Simon
    Wang, Raymond Y.
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [49] X-Linked Spinal Muscular Atrophy 2 due to a Synonymous Variant in the UBA1 Gene in a Family with Novel Findings from Turkey
    oeztuerk, Oezden
    cavdartepe, Buesra Eser
    Bagis, Haydar
    MOLECULAR SYNDROMOLOGY, 2022, 13 (03) : 246 - 253
  • [50] SPK-8011: Preliminary results from a phase 1/2 trial of investigational gene therapy for hemophilia A
    George, L. A.
    Ragni, M.
    Sullivan, S. K.
    Barrett, J. C.
    Samelson-Jones, B. J.
    Cuker, A.
    Cole, G.
    Wright, F.
    Chen, Y.
    Hui, D. J.
    Liu, Y.
    Wachtel, K.
    Takefman, D.
    Couto, L. B.
    Reape, K.
    Carr, M. E.
    Anguela, X. M.
    High, K. A.
    HAEMOPHILIA, 2018, 24 : 30 - 31
12345